MiniMed™ 780G insulin pump system
Life with insulin-requiring type 2 diabetes just got easier
Worry less about perfect carb counts with the system that automatically gives you extra insulin if you need it.†
Spend less time and effort managing diabetes
Leave behind the hassle of daily injections with our automated insulin pump that works in the background. Check out these features of the MiniMed™ 780G system:
Take the stress out of meal time
Meal Detection™ technology‡ automatically adjusts insulin
Stress less about perfect carb counting†
No need for exact carb counts—automatic insulin adjustments help prevent post-meal highs.
Reduce the work of diabetes care
Skip daily injections with a pump featuring a 300 mL reservoir, for higher insulin needs, and a 7-day infusion set for fewer changes.
Proven results and long-term benefits
Increase Time in Range1 with a system that stabilizes your glucose levels and helps prevent future complications.
Preset boluses
Make mealtime dosing simpler with preset doses in manual mode.
More restful nights
Sleep better with a system that anticipates, adjusts, and corrects all day and night.†
Benefit from 24/7 glucose control with insulin pump therapy
The MiniMed™ 780G system offers more glucose control than injections, delivering these potential benefits for people with insulin-requiring type 2 diabetes:
- Increased Time in Range1
- Up to 96% less insulin injections◊
- Reduced risk for long-term complications2,3
Get started
Understanding how insulin pumps work
Explore how insulin pump therapy simplifies diabetes management by delivering precise, automated insulin adjustments to the body through a thin, flexible tube called an infusion set.
The MiniMed™ 780G system components
-
Insulin pump
Based on information received from the CGM every 5 minutes, the insulin pump makes automatic adjustments and corrections† to your insulin delivery. -
Continuous glucose monitor (CGM)
Our sensors measure sugar levels every 5 minutes, sending levels to the pump. The Simplera Sync™ sesnor is our first all-in-one disposable CGM inserts in less than 10 seconds! -
Infusion set
Allows for continuous and discreet delivery of insulin through a thin, flexible tube. Get up to 7 days of wear time with the Medtronic Extended™ infusion set.
Life with type 2 diabetes, and stories that inspire.
Our technology empowers your journey, turning old routines into new freedom by simplifying diabetes management.
“The MiniMed™ 780G system has simplified the management of my diabetes. It all but eliminated the need for finger sticks in SmartGuard™ technology,§ and it manages my insulin delivery every five minutes around the clock with auto corrections."
Larry, MiniMed Champion and T2DGet notified of highs and lows
Our mobile apps seamlessly connect the insulin pump system together with your smartphone and Apple® Watch to keep you in the know!
You will be able to display key insulin pump data right on your compatible smart device! Discover a new way to interact with your MiniMed™ insulin pump and continuous glucose monitoring (CGM) data.
Your care partners can have an easy way to remotely view your glucose levels and insulin pump information if you choose.
| Water resistance | At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water. The pump is not intended for submersion in water and is expected to be removed prior to swimming or bathing. |
|---|---|
| Environmental conditions | The MiniMed™ 780G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump operating temperature range is from 41 °F (5 °C) to 98.6 °F (37 °C). Pump storage temperature range is from -4° F (-20° C) to 122° F (50° C). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi). |
| Altitude range |
|
| Insulin type | Rapid-acting U100 insulin (Humalog® and NovoLog®) that has been prescribed by a healthcare professional. |
| Bolus delivery | Bolus Speeds
|
| Programming increments |
|
| Basal rate delivery | 0 to 35 units per hour or the Max Basal Rate amount, whichever is lower. |
| Screen |
|
| Battery & power | The pump requires one new AA (1.5 V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery. |
| Pump memory | At any time, you can review 30 days of pump history. |
| Size | The pump dimensions in inches are approximately 2.1 width x 3.78 length x 0.96 depth. The weight of the pump is approximately 3 ounces. |
| Warranty |
|
Compatible products |
|
| Reservoir | Medtronic reservoir MMT-332A, 3.0 ml (300-units), Medtronic reservoir MMT0326A, 1.8 ml (180-units). |
| Infusion sets | Medtronic Diabetes offers a wide range of infusion sets so that you can choose the right one for your comfort and safety. |
MiniMed insulin pumps are covered by most insurance plans. Your out-of-pocket cost varies depending on your insurance. We also offer financial assistance and monthly payment programs. If you would like to check your insurance coverage, call us at 1-888-350-5440 (M-F, 9 a.m. to 6 p.m.).
For customers currently on a MiniMed insulin pump, sign in to Diabetes.shop to see your options.
Yes the MiniMed™ 780G system, is covered by Medicare and Medicare Advantage.
For new customers looking to order the MiniMed™ 780G system, fill out our form.
For customers currently on a MiniMed insulin pump, sign in to Diabetes.shop to see your options.
If you currently use an in-warranty insulin pump from another manufacturer, you may be eligible for our Switch2System program when you trade in your current device.
Simply trade in your existing pump and pay an upgrade fee of just $499 to switch to the MiniMed™ 780G system. If it doesn’t work out, no problem! You have 90 days to see if the system is right for you or you can return it. Learn more about our Switch2System program.
The MiniMed™ 780G system is approved for people with type 1 diabetes ages 7 and over.
Following your diabetes treatment plan and monitoring your glucose are important daily steps to take to prevent hyperglycemia concerns. However, the MiniMed™ 780G system features Meal Detection™ technology‡ that can detect if you’ve missed a meal dose and give you more insulin when you need it to help reduce post-meal hyperglycemia.† Always consult your healthcare team to find out what treatment is right for you.
To check if your smartphone or your Apple® Watch models are compatible, please visit our compatibility tool.
MiniMed™ Mobile app for people living with diabetes:
View your diabetes data on your smartphone or Apple® Watch, so you can easily track your glucose levels and get notified if you’re trending high or low. The app also enables automatic uploads of pump and CGM data to CareLink™ software so you can view trends and access reports about your system.
If you are a healthcare professional, we encourage you to visit our Medtronic professional diabetes healthcare website.
Footnotes
† Refers to SmartGuard™ feature. Individual results may vary.
‡ Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
§ Fingersticks required in manual mode & to enter smartguard. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.
◊ Assumes 4 injections per day for 30 days and one infusion set change every two to three days.
References
- Thijs I, et al. JDST. 2025. https://doi.org/10.1177/193229682513183
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
- U.K. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998;352:837-853
Important safety information: MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor
The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G Insulin Pump, the Guardian™ 4 Transmitter, the Guardian™ 4 Sensor, One-press serter, the Accu-Chek™Guide Link blood glucose meter, and the Accu-Chek™Guide Test Strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 Sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ (4) sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library